Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation
Respiratory failure in the premature newborn may be complicated by pulmonary hypertension (PAH) that does not always respond to conventional therapies. Conventional therapy for PAH involves: respiratory support, surfactant administration, sedation and / or muscle relaxation and inotropic agents in t...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2020-09-01
|
Series: | Romanian Journal of Pediatrics |
Subjects: | |
Online Access: | https://rjp.com.ro/articles/2020.3/RJP_2020_3_EN_Art-09.pdf |
id |
doaj-0d49f131aac7420d9b4e908e22db9f45 |
---|---|
record_format |
Article |
spelling |
doaj-0d49f131aac7420d9b4e908e22db9f452021-09-02T21:33:08ZengAmaltea Medical Publishing HouseRomanian Journal of Pediatrics1454-03982069-61752020-09-0169325125510.37897/RJP.2020.3.9Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentationMihaela Demetrian0Georgeta Grecu1Andreea Vidru2Andreea Calomfirescu-Avramescu3Alina Ciuca4Anca Panaitescu5”Filantropia” Clinical Hospital, Bucharest, Romania”Filantropia” Clinical Hospital, Bucharest, Romania”Filantropia” Clinical Hospital, Bucharest, Romania”Filantropia” Clinical Hospital, Bucharest, Romania“Grigore Alexandrescu“ Children’s Emergency Clinical Hospital, Bucharest, Romania “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaRespiratory failure in the premature newborn may be complicated by pulmonary hypertension (PAH) that does not always respond to conventional therapies. Conventional therapy for PAH involves: respiratory support, surfactant administration, sedation and / or muscle relaxation and inotropic agents in the most premature patients. Our experience in nitric oxide therapy in premature infants under 32 weeks dates back approximately 5 years. There were 7 cases of premature infants with respiratory failure who did not respond to conventional methods of therapy. We will present three case reports with hypoxic respiratory failure and severe pulmonary hypertension that responded favorably to nitric oxide therapy.https://rjp.com.ro/articles/2020.3/RJP_2020_3_EN_Art-09.pdfpremature infantspulmonary hypertensioninhaled nitric oxide |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mihaela Demetrian Georgeta Grecu Andreea Vidru Andreea Calomfirescu-Avramescu Alina Ciuca Anca Panaitescu |
spellingShingle |
Mihaela Demetrian Georgeta Grecu Andreea Vidru Andreea Calomfirescu-Avramescu Alina Ciuca Anca Panaitescu Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation Romanian Journal of Pediatrics premature infants pulmonary hypertension inhaled nitric oxide |
author_facet |
Mihaela Demetrian Georgeta Grecu Andreea Vidru Andreea Calomfirescu-Avramescu Alina Ciuca Anca Panaitescu |
author_sort |
Mihaela Demetrian |
title |
Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation |
title_short |
Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation |
title_full |
Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation |
title_fullStr |
Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation |
title_full_unstemmed |
Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation |
title_sort |
inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation |
publisher |
Amaltea Medical Publishing House |
series |
Romanian Journal of Pediatrics |
issn |
1454-0398 2069-6175 |
publishDate |
2020-09-01 |
description |
Respiratory failure in the premature newborn may be complicated by pulmonary hypertension (PAH) that does not always respond to conventional therapies. Conventional therapy for PAH involves: respiratory support, surfactant administration, sedation and / or muscle relaxation and inotropic agents in the most premature patients.
Our experience in nitric oxide therapy in premature infants under 32 weeks dates back approximately 5 years. There were 7 cases of premature infants with respiratory failure who did not respond to conventional methods of therapy.
We will present three case reports with hypoxic respiratory failure and severe pulmonary hypertension that responded favorably to nitric oxide therapy. |
topic |
premature infants pulmonary hypertension inhaled nitric oxide |
url |
https://rjp.com.ro/articles/2020.3/RJP_2020_3_EN_Art-09.pdf |
work_keys_str_mv |
AT mihaelademetrian inhalednitricoxidetheraphyinpreterminfantswithseverepulmonarydistresssyndromecasespresentation AT georgetagrecu inhalednitricoxidetheraphyinpreterminfantswithseverepulmonarydistresssyndromecasespresentation AT andreeavidru inhalednitricoxidetheraphyinpreterminfantswithseverepulmonarydistresssyndromecasespresentation AT andreeacalomfirescuavramescu inhalednitricoxidetheraphyinpreterminfantswithseverepulmonarydistresssyndromecasespresentation AT alinaciuca inhalednitricoxidetheraphyinpreterminfantswithseverepulmonarydistresssyndromecasespresentation AT ancapanaitescu inhalednitricoxidetheraphyinpreterminfantswithseverepulmonarydistresssyndromecasespresentation |
_version_ |
1717819702555705344 |